http://www.cuebiopharma.com
Cue Biopharma, Inc. Company Intro
Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells), is designed to harness the body’s intrinsic immune system without […]
Industry
Healthcare
Cue Biopharma, Inc. Headquaters
21 Erie Street
Cambridge,02139
United States
Cue Biopharma, Inc. Share price
21 Oct 2020 01:26 GMT
$15.35
0.02 (0.13 %)
Cue Biopharma, Inc. Market cap
$416.784 M
WMC RANKING
2020
Cue Biopharma, Inc. # 190
BiotechnologyLatest Cue Biopharma, Inc. News
19 Oct 2020
Cue Biopharma Announces Upcoming Scientific ...
/EIN News/ -- CAMBRIDGE, Mass., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company ...
15 Oct 2020
Cue Biopharma Inc (CUE) Stock: Buy, Hold, or Sell?
That average rating earns Cue Biopharma Inc an Analyst Ranking of 80, which means it ranks higher than 80 of stocks, based on data compiled by ...
15 Oct 2020
Cue Biopharma Inc (CUE) Stock: Buy, Hold, or Sell?
That average rating earns Cue Biopharma Inc an Analyst Ranking of 80, which means it ranks higher than 80 of stocks, based on data compiled by ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Cue Biopharma, Inc. | 0.06 | 0.32 | 2.68 | 0 | 0 | 0 | 2.25 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.15 | 100 | 19 | 0 | 0 | 98.93 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 3.89 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.02 |
| Incyte Corporation | 40.27 | 14.26 | 7.06 | 100 | 0 | 0 | 90.93 |
Cue Biopharma, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Cue Biopharma, Inc. | $3,458 | $40,228 | $-36,699 | $416.784M | 190 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $27.177B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.881B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥20.867B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.532B | 4 |